(Q41220150)

28 September 2017

1 reference

title

Occupational and environmental influences on scleroderma (English)

1 reference

28 September 2017

Silman AJ

1

1 reference

PubMed ID

8923593

28 September 2017

Hochberg MC

series ordinal

2

1 reference

28 September 2017

1 November 1996

1 reference

Rheumatic Diseases Clinics of North America

28 September 2017

1 reference

28 September 2017

22

1 reference

28 September 2017

4

1 reference

28 September 2017

737-749

1 reference

Scleroderma after therapy with appetite suppressants. Report on four cases

28 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970298-2

7 January 2021

A sclerodermatous syndrome with unusual features following prolonged occupational exposure to organic solvents.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970298-2

7 January 2021

Features of systemic sclerosis (scleroderma) in an identical twin pair

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970298-2

7 January 2021

The prevalence of women with breast implants in the United States--1989

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970298-2

7 January 2021

The breast implant controversy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970298-2

7 January 2021

Systemic sclerosis and exposure to trichloroethylene.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970298-2

7 January 2021

Benzene exposure and systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970298-2

7 January 2021

Autoimmune disease following the use of silicone gel-filled breast implants: a review of the clinical literature

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970298-2

7 January 2021

Scleroderma and augmentation mammoplasty--a causal relationship?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970298-2

7 January 2021

Risk of connective-tissue diseases and other disorders after breast implantation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970298-2

7 January 2021

Trends in the utilization of silicone breast implants, 1964-1991, and methodology for a population-based study of outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970298-2

7 January 2021

Systemic sclerosis and organic solvents: early diagnosis in industry

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970298-2

7 January 2021

Silicone breast prostheses and rheumatic symptoms: a retrospective follow up study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970298-2

7 January 2021

Breast implants, rheumatoid arthritis, and connective tissue diseases in a clinical practice

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970298-2

7 January 2021

Environmental scleroderma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970298-2

7 January 2021

Self-reported breast implants and connective-tissue diseases in female health professionals. A retrospective cohort study.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970298-2

7 January 2021

Cosmetic surgical procedures and connective tissue disease: the Cleopatra syndrome revisited

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970298-2

7 January 2021

Silicone breast implants and rheumatic disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970298-2

7 January 2021

Lack of association between augmentation mammoplasty and systemic sclerosis (scleroderma)

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970298-2

7 January 2021

Clinical spectrum of connective tissue disease after cosmetic surgery. Observations on eighteen patients and a review of the Japanese literature

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970298-2

7 January 2021

Silicone breast implants and long-term health effects: when are data adequate?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970298-2

7 January 2021

Antinuclear antibodies in the relatives and spouses of patients with systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970298-2

7 January 2021

Geographic clustering of scleroderma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970298-2

7 January 2021

Re: Breast implants, cancer, and systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970298-2

7 January 2021

Systemic sclerosis secondary to occupational exposure

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970298-2

7 January 2021

Skin manifestations of pentazocine abuse.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970298-2

7 January 2021

The association of progressive systemic sclerosis (scleroderma) with coal miners' pneumoconiosis and other forms of silicosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970298-2

7 January 2021

A new syndrome with pigmentation, scleroderma, gynaecomastia, Raynaud's phenomenon and peripheral neuropath

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970298-2

7 January 2021

Silicone breast implants and rheumatic disease. Clinical, immunologic, and epidemiologic studies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970298-2

7 January 2021

Silicone Breast Implants and the Risk of Connective-Tissue Diseases and Symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970298-2

7 January 2021

An epidemiological study of scleroderma in the West Midlands

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970298-2

7 January 2021

What is the contribution of occupational environmental factors to the occurrence of scleroderma in men?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970298-2

7 January 2021

Development of a scleroderma-like illness during therapy with L-5-hydroxytryptophan and carbidopa

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970298-2

7 January 2021

Breast silicone implants and risk of systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970298-2

7 January 2021

Cocaine abuse and connective tissue disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970298-2

7 January 2021

Systemic scleroderma, A clinical study of 727 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970298-2

7 January 2021

Post-mammoplasty connective tissue disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970298-2

7 January 2021

Clinical manifestations and course of vinyl chloride disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970298-2

7 January 2021

SOLVENTS AND SCLERODERMA

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970298-2

7 January 2021

Do solvents cause scleroderma?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970298-2

7 January 2021

Connective-tissue disease following breast augmentation: a preliminary test of the human adjuvant disease hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970298-2

7 January 2021

Occupational scleroderma-like disorder occurring in men engaged in the polymerization of epoxy resins

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970298-2

7 January 2021

Autoimmunity and selected environmental factors of disease induction

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970298-2

7 January 2021

10.1016/S0889-857X(05)70298-2

Identifiers

DOI

1 reference

28 September 2017

1 reference

PubMed ID

8923593